Finally, we will explore how semaglutide can be combined with other cholesterol-lowering strategies
Individual outcomes vary by adherence, baseline BMI, comorbidities, diet, and resistance training
But some research suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic, may cause side effects more often in females than males
Harrison SA, Browne SK, Suschak JJ et al (2025) Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study
A better and more defensible statement is this: retatrutide may create a better body-composition opportunity, but actual muscle retention or gain still depends on training, protein, recovery, and treatment design